Cargando…

Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice

The Middle East respiratory syndrome (MERS) is a fatal acute viral respiratory disease caused by MERS-coronavirus (MERS-CoV) infection. To date, no vaccine has been approved for MERS-CoV despite continuing outbreaks. Inactivated vaccines are a viable option when developed using the appropriate inact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Nayoung, Lee, Tae-Young, Lee, Hansaem, Yang, Jeong-Sun, Kim, Kyung-Chang, Lee, Joo-Yeon, Kim, Hyun-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693512/ https://www.ncbi.nlm.nih.gov/pubmed/36366352 http://dx.doi.org/10.3390/vaccines10111843

Ejemplares similares

Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice
por: Lee, Tae-Young, et al.
Publicado: (2021)

J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases
por: Lee, Hansaem, et al.
Publicado: (2022)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
por: Lyoo, Kwang-Soo, et al.
Publicado: (2023)

A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
por: Park, Jung-Eun, et al.
Publicado: (2022)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Immunogenic Epitope-Based Vaccine Prediction from Surface Glycoprotein of MERS-CoV by Deploying Immunoinformatics Approach
por: Nguyen, Truc Ly, et al.
Publicado: (2022)

MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice
por: Kim, Hye-Jung, et al.
Publicado: (2020)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice
por: Won, Hyeran, et al.
Publicado: (2023)

Investigation of nonlinear epidemiological models for analyzing and controlling the MERS outbreak in Korea
por: Ahn, Inkyung, et al.
Publicado: (2018)

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice
por: Mao, Qunying, et al.
Publicado: (2012)

Persistent Environmental Contamination and Prolonged Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea
por: Jeong, Hye Won, et al.
Publicado: (2015)

Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country
por: Song, Joon Young, et al.
Publicado: (2011)

Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study
por: Hyun, Hakjun, et al.
Publicado: (2022)

Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015
por: Kim, Dae-Won, et al.
Publicado: (2016)

MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017)

The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections
por: Jang, Tae-Ho, et al.
Publicado: (2022)

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity
por: Kim, C.-J., et al.
Publicado: (2016)

Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
por: Kim, Yeon-Sook, et al.
Publicado: (2020)

Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas
por: Chi, Hang, et al.
Publicado: (2022)

Post-traumatic stress symptoms in hemodialysis patients with MERS-CoV exposure
por: Cho, A Jin, et al.
Publicado: (2020)

Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents
por: Yoon, Seo Hee, et al.
Publicado: (2016)

Associations of health-related quality of life with depression and stigma in MERS-CoV survivors during the recovery period
por: Ahn, So-Hyun, et al.
Publicado: (2022)

Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines
por: Kandeel, Mahmoud, et al.
Publicado: (2023)

Considerations Left behind Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Outbreaks in Republic of Korea
por: Kim, Tae-Hee, et al.
Publicado: (2015)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

Host susceptibility to MERS-CoV infection, a retrospective cohort study of the 2015 Korean MERS outbreak
por: Ko, Jae-Hoon, et al.
Publicado: (2018)

Instant inactivation of aerosolized SARS-CoV-2 by dielectric filter discharge
por: Baek, Ki Ho, et al.
Publicado: (2022)

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein
por: Park, Byoung Kwon, et al.
Publicado: (2021)

The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015
por: Lee, Ji Yeon, et al.
Publicado: (2017)

10-mer and 9-mer WALK Peptides with Both Antibacterial and Anti-Inflammatory Activities
por: Kim, Su-Jin, et al.
Publicado: (2022)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
por: Kwak, Byung Ok, et al.
Publicado: (2020)

Production of a Monoclonal Antibody Targeting the M Protein of MERS-CoV for Detection of MERS-CoV Using a Synthetic Peptide Epitope Formulated with a CpG–DNA–Liposome Complex
por: Park, Byoung Kwon, et al.
Publicado: (2018)

An infectious cDNA clone of a growth attenuated Korean isolate of MERS coronavirus KNIH002 in clade B
por: Kim, Minwoo, et al.
Publicado: (2020)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein
por: Choi, Jung-ah, et al.
Publicado: (2020)

Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain
por: Jeon, Woo-Jin, et al.
Publicado: (2008)

An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice
por: In, Hyun Ju, et al.
Publicado: (2017)

Fast food diet-induced non-alcoholic fatty liver disease exerts early protective effect against acetaminophen intoxication in mice
por: Kim, Tae Hyung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6feeod1sd5isvgfvctbmsedche